Oppenheimer & Co’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,106
| Closed | -$35.4K | – | 1635 |
|
|
2024
Q4 | $35.4K | Sell |
12,106
-5,765
| -32% | -$16.8K | ﹤0.01% | 1532 |
|
|
2024
Q3 | $69.2K | Sell |
17,871
-3,160
| -15% | -$12.2K | ﹤0.01% | 1471 |
|
|
2024
Q2 | $108K | Buy |
21,031
+855
| +4% | +$4.4K | ﹤0.01% | 1382 |
|
|
2024
Q1 | $141K | Sell |
20,176
-422
| -2% | -$2.95K | ﹤0.01% | 1374 |
|
|
2023
Q4 | $182K | Sell |
20,598
-939
| -4% | -$8.32K | ﹤0.01% | 1296 |
|
|
2023
Q3 | $205K | Buy |
21,537
+6,152
| +40% | +$58.7K | ﹤0.01% | 1259 |
|
|
2023
Q2 | $225K | Buy |
15,385
+267
| +2% | +$3.91K | ﹤0.01% | 1254 |
|
|
2023
Q1 | $186K | Buy |
15,118
+1,106
| +8% | +$13.6K | ﹤0.01% | 1269 |
|
|
2022
Q4 | $260K | Buy |
+14,012
| New | +$260K | 0.01% | 1134 |
|